DK2425814T3 - Vand-i-olieemulsion til behandling af en øjensygdom - Google Patents

Vand-i-olieemulsion til behandling af en øjensygdom

Info

Publication number
DK2425814T3
DK2425814T3 DK10175337.4T DK10175337T DK2425814T3 DK 2425814 T3 DK2425814 T3 DK 2425814T3 DK 10175337 T DK10175337 T DK 10175337T DK 2425814 T3 DK2425814 T3 DK 2425814T3
Authority
DK
Denmark
Prior art keywords
treat
water
oil emulsion
eye disease
eye
Prior art date
Application number
DK10175337.4T
Other languages
English (en)
Inventor
Frederic Lallemand
Jean-Sebastien Garrigue
Original Assignee
Novagali Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novagali Pharma Sa filed Critical Novagali Pharma Sa
Application granted granted Critical
Publication of DK2425814T3 publication Critical patent/DK2425814T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK10175337.4T 2010-09-03 2010-09-03 Vand-i-olieemulsion til behandling af en øjensygdom DK2425814T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10175337.4A EP2425814B1 (en) 2010-09-03 2010-09-03 A water-in-oil type emulsion for treating a disease of the eye

Publications (1)

Publication Number Publication Date
DK2425814T3 true DK2425814T3 (da) 2013-09-08

Family

ID=43662067

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10175337.4T DK2425814T3 (da) 2010-09-03 2010-09-03 Vand-i-olieemulsion til behandling af en øjensygdom

Country Status (10)

Country Link
EP (1) EP2425814B1 (da)
CY (1) CY1114688T1 (da)
DK (1) DK2425814T3 (da)
ES (1) ES2426603T3 (da)
HR (1) HRP20130830T1 (da)
PL (1) PL2425814T3 (da)
PT (1) PT2425814E (da)
SI (1) SI2425814T1 (da)
SM (1) SMT201300101B (da)
UA (1) UA111168C2 (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10131910B2 (en) 2014-07-10 2018-11-20 Stichting Katholieke Universiteit Antisense oligonucleotides for the treatment of Usher syndrome type 2
GB201503408D0 (en) 2015-02-27 2015-04-15 Proqr Therapeutics N V Oligonucleotides
US10760076B2 (en) 2015-10-05 2020-09-01 Proqr Therapeutics Ii B.V. Use of single-stranded antisense oligonucleotide in prevention or treatment of genetic diseases involving a trinucleotide repeat expansion
CN113768879A (zh) 2016-03-16 2021-12-10 苏州澳宗生物科技有限公司 依达拉奉剂型
CN109310632A (zh) * 2016-04-12 2019-02-05 封装技术私人有限公司 用于递送生物活性剂的可注射组合物
CA3021899A1 (en) 2016-04-25 2017-11-02 Proqr Therapeutics Ii B.V. Oligonucleotides to treat eye disease
GB201616202D0 (en) 2016-09-23 2016-11-09 Proqr Therapeutics Ii Bv Antisense oligonucleotides for the treatment of eye deisease
US11236333B2 (en) 2016-12-13 2022-02-01 Stichting Katholieke Universiteit Antisense oligonucleotides for the treatment of Stargardt disease
GB201706009D0 (en) 2017-04-13 2017-05-31 Proqr Therapeutics Ii Bv Antisense oligonucleotides for the treatment of stargardt disease
EP3824086A1 (en) 2018-07-19 2021-05-26 Stichting Katholieke Universiteit Antisense oligonucleotides rescue aberrant splicing of abca4
US20220049250A1 (en) 2018-12-04 2022-02-17 Stichting Katholieke Universiteit Antisense Oligonucleotides Rescue Aberrant Splicing of ABCA4
US20220098584A1 (en) 2019-01-28 2022-03-31 Proqr Therapeutics Ii B.V. Antisense oligonucleotides for the treatment of leber`s congenital amaurosis
WO2020212567A1 (en) 2019-04-18 2020-10-22 Proqr Therapeutics Ii B.V. Antisense oligonucleotides for the treatment of usher syndrome
CN110090225B (zh) * 2019-04-19 2021-07-16 济南康和医药科技有限公司 一种依达拉奉氯化钠注射液及其制备方法
EP4010475A1 (en) 2019-08-08 2022-06-15 UCL Business Ltd Antisense oligonucleotides rescue aberrant splicing of abca4
IT201900019190A1 (it) 2019-10-17 2021-04-17 Univ Politecnica Delle Marche Derivato dell’epigallocatechina gallato
US20230134677A1 (en) 2020-03-04 2023-05-04 Proqr Therapeutics Ii B.V. Antisense oligonucleotides for use in the treatment of usher syndrome
WO2022090256A1 (en) 2020-10-26 2022-05-05 Proqr Therapeutics Ii B.V. Antisense oligonucleotides for the treatment of stargardt disease
WO2024074670A1 (en) 2022-10-06 2024-04-11 Stichting Radboud Universitair Medisch Centrum Antisense oligonucleotides for treatment of usher 2a. exon 68
AU2024323932A1 (en) 2023-08-11 2026-03-12 Stichting Radboud Universitair Medisch Centrum Antisense oligonucleotides for treatment of usher 2a. exon 53
WO2025186392A1 (en) 2024-03-06 2025-09-12 Stichting Radboud Universitair Medisch Centrum Therapeutics abca4 genome editing for treatment of stargardt disease
WO2026094043A1 (en) * 2024-10-31 2026-05-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Cns delivery of iron-chelators

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1318539B1 (it) 2000-05-26 2003-08-27 Italfarmaco Spa Composizioni farmaceutiche a rilascio prolungato per lasomministrazione parenterale di sostanze idrofile biologicamente
US6417237B1 (en) * 2000-06-08 2002-07-09 The Board Of Trustees Of The University Of Illinois Macromolecular drug complexes and compositions containing the same
CA2478825C (fr) * 2002-03-12 2012-01-24 Ethypharm Composition a proprietes gelifiantes destinee a la delivrance prolongee de substances bio-actives
EP1867323A1 (en) * 2006-06-13 2007-12-19 Farmatron Ltd. Pharmaceutical compositions with biological barriers permeation enhancing properties
US9125807B2 (en) 2007-07-09 2015-09-08 Incept Llc Adhesive hydrogels for ophthalmic drug delivery
WO2009046198A2 (en) 2007-10-02 2009-04-09 Potentia Pharmaceuticals, Inc. Sustained delivery of compstatin analogs from gels

Also Published As

Publication number Publication date
PL2425814T3 (pl) 2013-11-29
CY1114688T1 (el) 2016-10-05
EP2425814A1 (en) 2012-03-07
EP2425814B1 (en) 2013-06-19
UA111168C2 (uk) 2016-04-11
PT2425814E (pt) 2013-09-02
SMT201300101B (it) 2013-11-08
HRP20130830T1 (en) 2013-10-11
SI2425814T1 (sl) 2013-10-30
ES2426603T3 (es) 2013-10-24

Similar Documents

Publication Publication Date Title
LT2506830T (lt) Akių emulsija
EP2419392A4 (en) perfluorocarbon emulsions
BR112013020106A2 (pt) composições de óleo
BR112012002231A2 (pt) emulsão óleo/água (o/w) espumável
BR112012004841A2 (pt) método de produção de emulsão de óleo/água
FR2962044B1 (fr) Emulsion lacrymimetique
EP2484339A4 (en) Oil-in-water-type emulsion composition
EP2889484A4 (en) Oil separator
EP2412362A4 (en) COMPOSITION OF A WATER EMULSION IN OIL
PL2717716T3 (pl) Wydobywanie oleju roślinnego
BR112014009785A2 (pt) método para tratar ou reduzir efp
BR112014001266A2 (pt) composição de óleo lubrificante
EP2821605A4 (en) Oil separator
DK3024501T3 (da) Billeddannelse af neurologisk sygdom
PL2720701T3 (pl) Terapeutyczne pozajelitowe zastosowanie oleju z kryla
EP2672970A4 (en) FORMS OF RIFAXIMINE AND APPLICATIONS THEREOF
BR112013017674A2 (pt) composições agrícolas compreendendo emulsões óleo em água
DK2721933T3 (da) Emulsion
EP2780539A4 (en) FORMATIONSFRAKTURIERUNG
KR102172671B9 (ko) 중유를 처리하는 방법
BR112014005905A2 (pt) composição de óleo lubrificante
PL2717887T3 (pl) Sposoby leczenia lub zapobiegania chorobie przeszczep przeciw gospodarzowi
EP2609902A4 (en) PREPARATION OF A WATER IN OIL EMULSION COSMETICS
CO6990703A2 (es) Desacificación de grasas y aceites
EP2760428A4 (en) WATER IN OIL-IN-WATER EMULSIONS